Characteristic | Interview participants | ||
---|---|---|---|
Trial participant (n = 28) | Declined trial participation (n = 20) | Total (n = 48) | |
Gender, % (n) | |||
 Male | 25% (12) | 22.91% (11) | 47.91% (23) |
 Female | 33.33% (16) | 18.75% (9) | 52.08% (25) |
Age in years, % (n) | |||
 ≤49 | 6.25% (3) |  | 6.25% (3) |
 50–69 | 31.25% (15) | 20.8% (9) | 50% (24) |
 70–89 | 20.83% (10) | 22.91% (11) | 43.75% (21) |
Household arrangements, % (n) | |||
 Living with others (e.g. spouse, children) | 54.17% (26) | 31.25% (15) | 85.42% (41) |
 Living alone | 4.16% (2) | 10.42% (5) | 14.58% (7) |
Ethnicity, % (n) | |||
 Anglo-Saxon/English | 35.41% (17) | 37.5% (18) | 72.92% (35) |
 Australian | 6.25% (3) |  | 6.25% (3) |
 Pacific Islander | 6.25% (3) |  | 6.35% (3) |
 Australasian | 2.08% (1) |  | 2.08% (1) |
 Scottish | 2.08% (1) |  | 2.08% (1) |
 Undisclosed | 6.25% (3) | 1.16% (2) | 10.41% (5) |
Education level, % (n) | |||
 Did not complete high school | 6.25% (3) |  | 6.25% (3) |
 High school | 50% (24) | 33.33% (16) | 83.33% (40) |
 Bachelor’s degree |  | 2.08% (1) | 2.08% (1) |
 Unknown | 2.08% (1) | 6.25% (3) | 8.33% (4) |
Primary cancer diagnosis, % (n) | |||
 Breast | 12.5% (6) | 12.5% (6) | 25% (12) |
 Prostate | 6.25% (3) | 14.58% (7) | 20.83% (10) |
 Lung | 8.33% (4) | 6.25% (3) | 14.58% (7) |
 Ovarian | 6.25% (3) |  | 6.25% (3) |
 Endometrial | 6.25% (3) |  | 6.25% (3) |
 Urothelial |  | 4.16% (2) | 4.16% (2) |
 Colorectal/rectal | 4.16% (2) |  | 4.16% (2) |
 Pancreatic | 4.16% (2) |  | 4.16% (2) |
 Other | 10.42% (5) | 4.16% (2) | 14.58% (7) |